BioWorld. Link to homepage.

Clarivate
  • BioWorld
  • BioWorld Science
  • BioWorld Asia
  • Data Snapshots
    • Biopharma
    • Medical technology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • NME Digest
  • Special reports
    • Infographics: Dynamic digital data analysis
    • Trump administration impacts
    • Under threat: mRNA vaccine research
    • BioWorld at 35
    • Biopharma M&A scorecard
    • Bioworld 2025 review
    • BioWorld MedTech 2025 review
    • BioWorld Science 2025 review
    • Women's health
    • China's GLP-1 landscape
    • PFA re-energizes afib market
    • China CAR T
    • Alzheimer's disease
    • Coronavirus
    • More reports can be found here

BioWorld. Link to homepage.

  • Sign In
  • Sign Out
  • My Account
Subscribe
BioWorld - Saturday, February 7, 2026
Home » Authors » Mark McCarty

Mark McCarty

Articles

ARTICLES

Washington roundup: Envoy wins panel nod for its Esteem hearing implant PMA

Dec. 22, 2009
By Mark McCarty
GAITHERSBURG, Maryland — The ear, nose and throat devices advisory committee met last week to take up the matter of the Esteem implant for hearing loss, made by Envoy Medical (St. Paul, Minnesota) and as is often the case of late with medical device advisory committees, the agency allowed the panel to take up a matter that is outside the panel's purview. (Medical Device Daily)
Read More

Washington roundup: AdvaMed opens new division for diagnostics member firms

Dec. 21, 2009
By Mark McCarty

Washington roundup: Small business group aims to tackle patent reform issues

Dec. 18, 2009
By Mark McCarty

Endotec tagged with warning letter for implant sterility

Dec. 17, 2009
By Mark McCarty

Washington roundup: Device tax would be delayed under new Senate amendment

Dec. 16, 2009
By Mark McCarty

Panel recommends RCTs for prostate cancer treatments

Dec. 16, 2009
By Mark McCarty
GAITHERSBURG, Maryland – As some device makers tell it, enrolling patients into a randomized clinical trial (RCT) is like getting dancers on the dance floor, at least in one respect; it's tough to get someone to be the first. Unlike the accumulation of dancers on the dance floor, however, the arrival of the first enrollee in an RCT does not ensure a landslide of participation. (Medical Device Daily)
Read More

Sharfstein says FDA not up for 'old standards' in new era

Dec. 15, 2009
By Mark McCarty

Ubl: $40 billion tax on medtech would be 'devastating'

Dec. 15, 2009
By Mark McCarty

Washington roundup: CMS excoriated after holding on carotid stenting coverage

Dec. 11, 2009
By Mark McCarty
The Centers for Medicare & Medicaid Services has wrestled for some time with the issue of reimbursement for angioplasty and stenting of the carotid artery in patients who are not good candidates for carotid artery endarterectomy (CAE), and yesterday's announcement that the agency would essentially hold its ground was not well received. One physician who has been involved in the issue for some time called the decision "an open stinking wound," but other voices say CMS already has plans to yield on coverage for high-risk patients. (Medical Device Daily)
Read More

CMS decides to reimburse for Medicare screening for HIV

Dec. 10, 2009
By Mark McCarty
View All Articles by Mark McCarty

Popular Stories

  • Today's news in brief

    BioWorld
    BioWorld briefs for Feb. 6, 2025.
  • Brain illustration

    MJFF grant supports Bexorg’s translational biomarker work

    BioWorld Science
    Bexorg Inc. has been awarded a research grant from The Michael J. Fox Foundation for Parkinson’s Research (MJFF) through the Targets to Therapies initiative to...
  • Brain and DNA

    REST emerges as biomarker in ALS, knockdown improves ALS symptoms

    BioWorld Science
    About 10% of amyotrophic lateral sclerosis (ALS) cases result from inherited genetic mutations, with about 20% of them attributed to mutations in the gene...
  • Brain illustrated with pills

    Serotonin receptor modulators for the treatment of OUD

    BioWorld Science
    Opioid use disorder (OUD) causes high morbidity and mortality rates, with fentanyl driving unprecedented overdose rates. Researchers from the University of...
  • Liver anatomy illustration

    KLF15 shows potential as marker, target for cholangiocarcinoma

    BioWorld Science
    Researchers at the Biodonostia Health Research Institute reported on the role of KLF15 in cholangiocarcinogenesis and its potential as a therapeutic target in...
  • BioWorld
    • Today's news
    • Analysis and data insight
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Medical technology
    • Newco news
    • Opinion
    • Regulatory
  • BioWorld Science
    • Today's news
    • Biomarkers
    • Cancer
    • Conferences
    • Endocrine/metabolic
    • Immune
    • Infection
    • Neurology/psychiatric
    • NME Digest
    • Patents
  • BioWorld Asia
    • Today's news
    • Analysis and data insight
    • Australia
    • China
    • Clinical
    • Deals and M&A
    • Financings
    • Newco news
    • Regulatory
    • Science
  • More
    • About
    • Advertise with BioWorld
    • Archives
    • Article reprints and permissions
    • Contact us
    • Cookie policy
    • Copyright notice
    • Data methodology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • Podcasts
    • Privacy policy
    • Share your news with BioWorld
    • Staff
    • Terms of use
    • Topic alerts
Follow Us

Copyright ©2026. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing